Skip to main content
. 2024 May 6;14:1347742. doi: 10.3389/fonc.2024.1347742

Figure 3.

Figure 3

Cases 5 and 6 (novel substitution mutations) (A) Timeline of Case 5. (B) Timeline of Case 6. *whole brain radiotherapy. CDKN2A, cyclin-dependent kinase inhibitor 2A; EGFR, epidermal growth factor receptor; NGS, next-generation sequencing; NSCLC, non-small cell lung cancer; PD, progressive disease; PR, partial response; QD, each day; RT, radiotherapy; SD, stable disease; TP53, tumor protein 53.